[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Bladder Cancer Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

December 2018 | 115 pages | ID: G9F587085C0EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the innermost layer called urothelium or transitional epithelium, composed of epithelium or transitional cells.

Scope of the Report:

This report studies the Bladder Cancer Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Bladder Cancer Therapeutics market by product type and applications/end industries.
The availability of targeted therapy will be one of the major factors driving the growth prospects for the market until the end of 2021. The advancements in drug targeting techniques have enabled doctors to administer drugs directly into the bladder having tumors. This in turn, will help in avoiding side effects of these drugs on healthy cells. With a better understanding of tumor immunology scientists can also now develop new drugs targeted at cancer cells. TECENTRIQ and OPDIVO are the PD-L1 inhibitors recently approved by the US FDA for the treatment of urothelial carcinoma. One of the effective procedures for the diagnosis of bladder cancer, cystoscopy, involves the use of a long thin tube called cystoscope. This helps the urologist to extract a small piece of the abnormal tissue and send it to the pathologists for examination. With the emergence of effective diagnostic tools such as flexible cystoscope, urologists will prefer cystoscopy since it can be easily performed in the outpatient department. This emergence of effective diagnostic tools will be one of the major trends that will gain traction in the bladder cancer therapeutics market during the next four years.
The global Bladder Cancer Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Bladder Cancer Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
  • Bristol-Myers Squibb
  • Eli Lilly
  • F. Hoffman-La Roche
  • Pfizer
Market Segment by Regions, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Colombia)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
  • Transitional Cell Bladder Cancer
  • Invasive Bladder Cancer
  • Superficial Bladder Cancer
  • Squamous Cell Bladder Cancer
  • Others
Market Segment by Applications, can be divided into
  • Hospitals
  • Clinics
  • Other
1 BLADDER CANCER THERAPEUTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Bladder Cancer Therapeutics
1.2 Classification of Bladder Cancer Therapeutics by Types
  1.2.1 Global Bladder Cancer Therapeutics Revenue Comparison by Types (2017-2023)
  1.2.2 Global Bladder Cancer Therapeutics Revenue Market Share by Types in 2017
  1.2.3 Transitional Cell Bladder Cancer
  1.2.4 Invasive Bladder Cancer
  1.2.5 Superficial Bladder Cancer
  1.2.6 Squamous Cell Bladder Cancer
  1.2.7 Others
1.3 Global Bladder Cancer Therapeutics Market by Application
  1.3.1 Global Bladder Cancer Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Other
1.4 Global Bladder Cancer Therapeutics Market by Regions
  1.4.1 Global Bladder Cancer Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Bladder Cancer Therapeutics Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Bladder Cancer Therapeutics Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bladder Cancer Therapeutics Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Bladder Cancer Therapeutics Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bladder Cancer Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Bladder Cancer Therapeutics (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Bristol-Myers Squibb
  2.1.1 Business Overview
  2.1.2 Bladder Cancer Therapeutics Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Bristol-Myers Squibb Bladder Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eli Lilly
  2.2.1 Business Overview
  2.2.2 Bladder Cancer Therapeutics Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Eli Lilly Bladder Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 F. Hoffman-La Roche
  2.3.1 Business Overview
  2.3.2 Bladder Cancer Therapeutics Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 F. Hoffman-La Roche Bladder Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
  2.4.1 Business Overview
  2.4.2 Bladder Cancer Therapeutics Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Pfizer Bladder Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL BLADDER CANCER THERAPEUTICS MARKET COMPETITION, BY PLAYERS

3.1 Global Bladder Cancer Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Bladder Cancer Therapeutics Players Market Share
  3.2.2 Top 10 Bladder Cancer Therapeutics Players Market Share
3.3 Market Competition Trend

4 GLOBAL BLADDER CANCER THERAPEUTICS MARKET SIZE BY REGIONS

4.1 Global Bladder Cancer Therapeutics Revenue and Market Share by Regions
4.2 North America Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA BLADDER CANCER THERAPEUTICS REVENUE BY COUNTRIES

5.1 North America Bladder Cancer Therapeutics Revenue by Countries (2013-2018)
5.2 USA Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)

6 EUROPE BLADDER CANCER THERAPEUTICS REVENUE BY COUNTRIES

6.1 Europe Bladder Cancer Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC BLADDER CANCER THERAPEUTICS REVENUE BY COUNTRIES

7.1 Asia-Pacific Bladder Cancer Therapeutics Revenue by Countries (2013-2018)
7.2 China Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA BLADDER CANCER THERAPEUTICS REVENUE BY COUNTRIES

8.1 South America Bladder Cancer Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE BLADDER CANCER THERAPEUTICS BY COUNTRIES

9.1 Middle East and Africa Bladder Cancer Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)

10 GLOBAL BLADDER CANCER THERAPEUTICS MARKET SEGMENT BY TYPE

10.1 Global Bladder Cancer Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Bladder Cancer Therapeutics Market Forecast by Type (2018-2023)
10.3 Transitional Cell Bladder Cancer Revenue Growth Rate (2013-2023)
10.4 Invasive Bladder Cancer Revenue Growth Rate (2013-2023)
10.5 Superficial Bladder Cancer Revenue Growth Rate (2013-2023)
10.6 Squamous Cell Bladder Cancer Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)

11 GLOBAL BLADDER CANCER THERAPEUTICS MARKET SEGMENT BY APPLICATION

11.1 Global Bladder Cancer Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Bladder Cancer Therapeutics Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Other Revenue Growth (2013-2018)

12 GLOBAL BLADDER CANCER THERAPEUTICS MARKET SIZE FORECAST (2018-2023)

12.1 Global Bladder Cancer Therapeutics Market Size Forecast (2018-2023)
12.2 Global Bladder Cancer Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Bladder Cancer Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Bladder Cancer Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Bladder Cancer Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Bladder Cancer Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Bladder Cancer Therapeutics Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES

Figure Bladder Cancer Therapeutics Picture
Table Product Specifications of Bladder Cancer Therapeutics
Table Global Bladder Cancer Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Bladder Cancer Therapeutics Revenue Market Share by Types in 2017
Figure Transitional Cell Bladder Cancer Picture
Figure Invasive Bladder Cancer Picture
Figure Superficial Bladder Cancer Picture
Figure Squamous Cell Bladder Cancer Picture
Figure Others Picture
Table Global Bladder Cancer Therapeutics Revenue (Million USD) by Application (2013-2023)
Figure Bladder Cancer Therapeutics Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Other Picture
Table Global Market Bladder Cancer Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Bladder Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Bladder Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Bladder Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Bladder Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Bladder Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Bladder Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Bladder Cancer Therapeutics Type and Applications
Table Bristol-Myers Squibb Bladder Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Bladder Cancer Therapeutics Type and Applications
Table Eli Lilly Bladder Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffman-La Roche Basic Information, Manufacturing Base and Competitors
Table F. Hoffman-La Roche Bladder Cancer Therapeutics Type and Applications
Table F. Hoffman-La Roche Bladder Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Bladder Cancer Therapeutics Type and Applications
Table Pfizer Bladder Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Bladder Cancer Therapeutics Revenue (Million USD) by Players (2013-2018)
Table Global Bladder Cancer Therapeutics Revenue Share by Players (2013-2018)
Figure Global Bladder Cancer Therapeutics Revenue Share by Players in 2016
Figure Global Bladder Cancer Therapeutics Revenue Share by Players in 2017
Figure Global Top 5 Players Bladder Cancer Therapeutics Revenue Market Share in 2017
Figure Global Top 10 Players Bladder Cancer Therapeutics Revenue Market Share in 2017
Figure Global Bladder Cancer Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Bladder Cancer Therapeutics Revenue (Million USD) by Regions (2013-2018)
Table Global Bladder Cancer Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Bladder Cancer Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Bladder Cancer Therapeutics Revenue Market Share by Regions in 2017
Figure North America Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Bladder Cancer Therapeutics Revenue by Countries (2013-2018)
Table North America Bladder Cancer Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Bladder Cancer Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Bladder Cancer Therapeutics Revenue Market Share by Countries in 2017
Figure USA Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Bladder Cancer Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Bladder Cancer Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Europe Bladder Cancer Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure UK Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure France Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure Russia Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Bladder Cancer Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Bladder Cancer Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Bladder Cancer Therapeutics Revenue Market Share by Countries in 2017
Figure China Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure Japan Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure Korea Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure India Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Bladder Cancer Therapeutics Revenue by Countries (2013-2018)
Table South America Bladder Cancer Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Bladder Cancer Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Bladder Cancer Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure Argentina Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure Colombia Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Bladder Cancer Therapeutics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Bladder Cancer Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Bladder Cancer Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Bladder Cancer Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure UAE Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure Egypt Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure Nigeria Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Figure South Africa Bladder Cancer Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Bladder Cancer Therapeutics Revenue (Million USD) by Type (2013-2018)
Table Global Bladder Cancer Therapeutics Revenue Share by Type (2013-2018)
Figure Global Bladder Cancer Therapeutics Revenue Share by Type (2013-2018)
Figure Global Bladder Cancer Therapeutics Revenue Share by Type in 2017
Table Global Bladder Cancer Therapeutics Revenue Forecast by Type (2018-2023)
Figure Global Bladder Cancer Therapeutics Market Share Forecast by Type (2018-2023)
Figure Global Transitional Cell Bladder Cancer Revenue Growth Rate (2013-2018)
Figure Global Invasive Bladder Cancer Revenue Growth Rate (2013-2018)
Figure Global Superficial Bladder Cancer Revenue Growth Rate (2013-2018)
Figure Global Squamous Cell Bladder Cancer Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Bladder Cancer Therapeutics Revenue by Application (2013-2018)
Table Global Bladder Cancer Therapeutics Revenue Share by Application (2013-2018)
Figure Global Bladder Cancer Therapeutics Revenue Share by Application (2013-2018)
Figure Global Bladder Cancer Therapeutics Revenue Share by Application in 2017
Table Global Bladder Cancer Therapeutics Revenue Forecast by Application (2018-2023)
Figure Global Bladder Cancer Therapeutics Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Figure Global Bladder Cancer Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Bladder Cancer Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Bladder Cancer Therapeutics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Bladder Cancer Therapeutics Revenue Market Forecast (2018-2023)
Figure Europe Bladder Cancer Therapeutics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Bladder Cancer Therapeutics Revenue Market Forecast (2018-2023)
Figure South America Bladder Cancer Therapeutics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Bladder Cancer Therapeutics Revenue Market Forecast (2018-2023)


More Publications